New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
|Podcasts|November 4, 2019
Atypical Antipsychotics in Bipolar Depression
Author(s)Chris Aiken, MD
We have nearly a dozen atypical antipsychotics to choose from, but do all of these work in bipolar disorder and which of them should we start with? Listen to the podcast.
Advertisement
We have nearly a dozen atypical antipsychotics to choose from, but do all of these work in bipolar disorder and which of them should we start with? Listen to the podcast.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhD
2
New Adult ADHD Guidelines: What Resources Are Coming Soon
3
Brenipatide for Alcohol Use Disorder: Emerging Findings
4
The Silence Between the Questions: Reflections on Adolescent Suicide Risk When Intent Is Unclear
5